President Donald Trump's plan for tariffs on imports has guided the stock market's direction over the past few weeks. The ...

Two incumbents and five newcomers were elected in April, but the terms of President Shelly Parks and trustees Anna Firicano ...

The weight of losing my brother eventually settled in fully. The silence between us was louder than any excuse I could ...

Announced U.S. Food and Drug Administration (FDA) approval of VYKAT XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, for the treatment of hyperphagia in adults and ...

Casandra Ventura testified that she was “humiliated” by marathon sex sessions that were fueled by drugs and orchestrated by ...

Despite its reputation as ironclad, it was possible to escape Alcatraz. All it took was brains, guts and 50 raincoats.

IRVINE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to shareholders in conjunction with its first ...

Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of calendar 2025 -- --With positive Phase 2b QUALITY study, Veru plans for end of Phase 2 ...

Q1 2025 pharma services revenue of $2.1 million, at 62% gross marginThree of the top 10 U.S. transplant centers expected to participate in clinical trialTen globally leading transplant hospitals are ...

MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update ...

Through assiduous research and well-paced narrative, Simon Parkin has given us an extraordinary, little-known story from World War II: the turning point in the Battle of the Atlantic. Its subjects ...

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported ...